Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 09/10/2021
Closing price: 299.81
|Support price level:||N/A|
|Resistance price level:||$327.78|
|Relative strength index (14-day RSI)||16.0|
- BIIB is one of this month's worst performers with a return of -12.0%, underperforming 90 percent of stocks in the S&P-100.
- Down 10.7 percent, BIIB is one of this week's biggest decliners.
- The price of this low-beta stock is expected to increase by 0.11% for every 1% increase in the S&P-500.
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 69.9%.
- Volatility is forecast to fall over the next month.
- With RSI < 30, BIIB is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 19.0% in the next week.
- 27.7% in the next month.
- 114.8% in the next year.